• Maximize NIH and DOD Funding

    The FreeMind Group is the premier international consulting firm specializing in assisting life science organizations secure non-dilutive funding from US Federal Agencies and Private Foundations

    Watch Introductory VideoContact a funding expert

About Us

The FreeMind Group turns non-dilutive funding into a strategic source of funding for life science organizations

Meet us at an upcoming event:

Experience

Established in 1999, FreeMind is the largest consulting group of its kind working with academics and Industry alike. Our goal is to assist in maximizing potential to receive funding from non-dilutive sources. We have experience in seeking funding from nearly all NIH Institutes, Department of Defense, NSF, FDA, BARDA, etc., as well as private foundations.

Expertise

FreeMind’s knowledgeable and experienced team of Client Strategists and Project Managers are dedicated to guiding non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award. Our expertise in applying for grants and contracts extends throughout every government mechanism as well as private foundations open to funding the life sciences.

Success

FreeMind’s proven long-term strategic approach has garnered its clients over 1.5 billion dollars to date. Awards range from $150,000 to $150,000,000 per project. Our team of experts will assist in making non-dilutive funding a key tool in a long-term sound financial strategy.

Leadership

Ram May-Ron

Ram May-Ron

Managing Partner
Ayal Ronen, M.Sc., MBA

Ayal Ronen, M.Sc., MBA

Vice President
Guy Har-Chen, M.Sc., MBA

Guy Har-Chen, M.Sc., MBA

Chief Client Strategist
Joel Knopf, M.Sc., MBA

Joel Knopf, M.Sc., MBA

Manager of Consulting Services
Sigal Katz, Ph.D.

Sigal Katz, Ph.D.

Senior Client Strategist
Inna Grodzovski, Ph.D.

Inna Grodzovski, Ph.D.

Senior Client Strategist
Amit Sadeh, Ph.D.

Amit Sadeh, Ph.D.

Senior Client Strategist
Ariel Shatz

Ariel Shatz

Executive Vice President

Strategic Partners

THE PROCESS

  • Strategic Assessment

    Provides a robust, long-term, multi-submission granting strategy for each pipeline project. FreeMind is well versed in the interests, goals, and available funding opportunities of each funding source.

  • Macro Application Strategy

    Outline the specific aims, scope of work, budgetary needs, as well as delineate any collaborators, subcontractors, and consultants required. We devise a timeline to submission and set an orderly division of responsibilities.

  • Grant Production Process

    A combined writing effort, based on comprehensive templates drafted by project managers, yields the work product. The iterative review concludes when a well-structured scientifically sound application materializes.

  • Submission and Follow up

    Upon completion, the application is submitted. Post-submission we closely monitor the review process, and assist with pre-award negotiations, awaiting a final decision by the granting agency.

FreeMind’s knowledgeable and experienced team of Client Strategists and Project Managers are dedicated to guiding non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award

  • FreeMind did unbelievable job- and put in so many hrs today and all throughout the past few weeks. I don’t think we could have done it without such help from FreeMind and all of you!

    Nalini Motwani, Ph.D. - President, BioSavita
  • Many thanks for your excellent support. It was and continues to be our pleasure working with you, and we too look forward to embarking on a new grant project with you again soon.

    Maurits W. Geerlings - Formula Pharmaceuticals
  • Thank you all for your tireless, persistent efforts in pushing this through. We are now well positioned to let the considerable merits of our application shine through. Much appreciated.

    Jonathan Lim - IGNYTA
  • From the Immusoft, Thank you again for your efforts and guidance during the assemblage of our SBIR grant. We have improved our grantsmanship as a result of FMG’s involvement.

    Zach Hall – Immusoft
  • There is no way we would have been able to do it in such a short time without you.
    Thank you for all your help!!!

    Rudy Rodriguez - Advanced Animal Diagnostics
  • After a powerful joint effort as usual, and many careful iterations of edits, this proposal looks top-notch! Thanks to all for your participation in the success of this submission. Thank you Freemind, in particular, your hard work has greatly improved this proposal, you have been a tremendous help, right up to the end.

    Aileen Gibbons - Respira Therapeutics, Inc.
  • Thank you very much. Writing this grant proposal has been very insightful to me, and the Freemind team made it a very smooth process.

    Ed Buurman – Astrazeneca
  • I LOVE working with you guys!! ……..Your true entrepreneurial approach is just what I needed right now…….

    Tim Bertram, Tengion
  • FreeMind has added a lot of value to the proposal, driving us perfectly through the process, the exact role we were expecting

    Luis Ruiz-Avila - Janus Developements
  • We are very satisfied with the role and involvement of FreeMind on our project. All has been submitted on time with a great interaction (and hard work) between our two teams.

    Eric Massou, Poxel
  • Thanks so much for all of your help on this proposal!  I am so grateful that you were available to work with us, and I don’t think we could have done it without you.

    Meghan Norvell, nanoMR
  • You did a fantastic job for Embolx and I continue to recommend FreeMind to entrepreneurs here is Silicon Valley.

    Michael Allen - President and CEO, Embolx

LEARN

Non Dilutive Funding – Non di-lu’-tive Fund-ing

1. funding – financial resources provided to make some project possible; “The National Institutes of Health (NIH) provided funding for the experiment.”

2. non-dilutive funding – the act of financing R&D activity not traded for public securities and/or shares of a commercial entity; “The FreeMind Group assisted in securing non-dilutive funding from the Department of Defense for a Phase II clinical trial.”

Free Educational Webinars

Listen to FreeMind experts and learn about non-dilutive sources of funding relevant to you.

Participation is FREE of Charge, Registration is Required

Upcoming Webinars

April 5, 2017

Non-Dilutive Funding Opportunities for Cancer R&D

more information

NIH alone awards roughly $6B annually to Cancer related R&D grants and contracts. The scope of funding support covers much of the R&D cycle with an emphasis on pre-clinical work, and may cover clinical stage activities as well.

In the upcoming webinar, we will discuss key cancer related opportunities, mainly within the National Cancer Institute (NCI), that are available for life science organizations.

May 3, 2017

Congressionally Directed Medical Research Programs

more information

The Congressionally Directed Medical Research Programs (CDMRP), are supported by funds allocated by Congress for biomedical research in response to the needs of the American people and military.

The FY2016 budget was over $800 million, with funds allocated to go towards supporting R&D efforts in various stages of development. Some research areas covered include Breast Cancer and Multiple Sclerosis as well as several additional Peer Reviewed topics such as Alzheimer’s and Cancer, and others.

In this webinar we will discuss the various programs, the process for applying, guidelines, key success components and insight into increasing chances for award.

June 7, 2017

Funding Opportunities for Pre-Clinical Stage Research

more information

Every year, US-based non-dilutive sources of funding award billions of dollars towards pre-clinical stage research in the Life Sciences.

Funding is available for pre-clinical research across scientific fields including Infectious Diseases, Oncology, Neurosciences, and many more. These funds come from Institutes within the NIH, such as NIAID, NCI, NINDS, the NSF, the DoD, and private foundations. The NIH alone annually funds over $15B to pre-clinical stage R&D in the life sciences.

In this webinar we will the discuss process for applying, guidelines, key success components, and insight into increasing chances for award.

July 5, 2017

Introduction to the SBIR/STTR Funding Mechanisms

more information

Coming soon!

The webinars are designed for first timers as well as seasoned grantees. FreeMind experts will share their insight into various areas of interest as they relate to non-dilutive sources of funding and how to maximize chances for award.

For any inquiries, please email Irina Rajkovetsky: Send Mail

All Webinars are recorded and posted on the FreeMind Group Educational YouTube Channel

JOIN A WEBINAR

FreeMind’s knowledgeable team of expert grant writers share their wisdom on how to maximize chances for award.

Join our mailing list by typing in your email address here:

* Don’t worry, we hate spam as much as you do.

Get in touch with us

For any inquiry or question please contact us by phone or email.

Email us:

info @ freemindconsultants.com

US Office

FreeMind Group
423 Brookline Ave. #124
Boston, MA 02215

 

Tel: (617) 648-0340
Fax: (617) 904-1767

International Office

FreeMind Group
Hi – Tech Center
Hebrew University
Jerusalem 95702 Israel

 

Tel: +972 (0)2-6799833
Fax: +972 (0)2-6799834

Contact us using this form

Attend the 13th Annual Non-Dilutive Funding Summit

January 10, 2018 – Marines Memorial Club, San Francisco, CA

More from the FreeMind Group

Eagle Point Funding

Eagle Point Funding helps cyber security and defense organizations secure government grants and contracts.

Contact us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Questions, issues or concerns? I'd love to help you!

Click ENTER to chat